At the time of China's economic slowdown, the Ministry of Commerce of China held a round table for foreign -funded enterprises and emphasized that China puts foreign investment in a more important position.
According to a press release issued on Wednesday (July 5), the Ministry of Commerce of China, Wang Wentao, the Minister of Commerce of China, hosted a round table meeting of foreign -funded enterprises on the same day.Roche, Astrikan, Sanofi, Takeda, and Pfizer participated in the meeting.
Wang Wentao said to these participants at the meeting that China is comprehensively promoting the modernization of Chinese -style, and unswervingly promoting high -level opening to the outside world.EssenceThe Chinese government puts foreign investment in a more important position and continuously optimizes the business environment.
Wang Wentao pointed out that according to the deployment of the State Council of China, the Ministry of Commerce of China relying on the foreign trade and foreign capital coordination service mechanism, based on the existing normal communication mechanism, upgrade the establishment of a round table system for foreign -funded enterprises."We will regularly organize meetings through this mechanism arrangement, further expand the channels for collecting collections, listen to suggestions, and respond to solving corporate concerns in a timely manner, and help foreign companies have developed in China for a long time and stable development in China."
The participating enterprises said that they are confident in the prospects of China's economic development and are willing to strengthen communication with government departments through channels such as foreign companies' round tables.According to the press release, the participating companies also introduced foreign -funded operations and problems in the pharmaceutical industry, and put forward 25 specific opinions and suggestions.
Representatives of the Ministry of Finance, the National Intellectual Property Office, the State Medical Insurance Bureau, the State Drug Administration and other departments also attended the meeting.